Essex Investment Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
2018
Q3
$2.27M Sell
2018
Q2
$2M Sell
2018
Q1
$4.2M Buy
2017
Q4
$583K Buy
2017
Q3
$598K Sell
2017
Q2
$862K Buy
2017
Q1
$225K Buy
2016
Q2
Sell
2016
Q1
$492K Buy